Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users.

Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh DC, Montaner JS, Tyndall MW.

Harm Reduct J. 2004 Nov 9;1(1):9.

2.

Rationale for evaluating North America's first medically supervised safer-injecting facility.

Wood E, Kerr T, Montaner JS, Strathdee SA, Wodak A, Hankins CA, Schechter MT, Tyndall MW.

Lancet Infect Dis. 2004 May;4(5):301-6.

PMID:
15120347
3.

Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.

Wood E, Tyndall MW, Montaner JS, Kerr T.

CMAJ. 2006 Nov 21;175(11):1399-404.

4.

Do supervised injecting facilities attract higher-risk injection drug users?

Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, Kerr T.

Am J Prev Med. 2005 Aug;29(2):126-30.

PMID:
16005809
5.
6.

The role of safer injection facilities in the response to HIV/AIDS among injection drug users.

Kerr T, Kimber J, Debeck K, Wood E.

Curr HIV/AIDS Rep. 2007 Dec;4(4):158-64. Review.

PMID:
18366946
7.

Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.

Wood RA, Wood E, Lai C, Tyndall MW, Montaner JS, Kerr T.

Int J Drug Policy. 2008 Jun;19(3):183-8. doi: 10.1016/j.drugpo.2008.01.003. Epub 2008 Mar 26.

PMID:
18367389
8.

The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility.

Fast D, Small W, Wood E, Kerr T.

Harm Reduct J. 2008 Oct 29;5:32. doi: 10.1186/1477-7517-5-32.

9.

Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility.

Wood E, Kerr T, Stoltz J, Qui Z, Zhang R, Montaner JS, Tyndall MW.

Public Health. 2005 Dec;119(12):1111-5. Epub 2005 Oct 7.

PMID:
16214189
10.
11.

The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.

Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, Hogg RS, O'Shaughnessy MV, Schechter MT.

J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):2-8.

PMID:
12514408
12.

Rate of detoxification service use and its impact among a cohort of supervised injecting facility users.

Wood E, Tyndall MW, Zhang R, Montaner JS, Kerr T.

Addiction. 2007 Jun;102(6):916-9.

PMID:
17523986
13.

Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.

Petrar S, Kerr T, Tyndall MW, Zhang R, Montaner JS, Wood E.

Addict Behav. 2007 May;32(5):1088-93. Epub 2006 Aug 22.

PMID:
16930849
14.

Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility.

Wood E, Tyndall MW, Qui Z, Zhang R, Montaner JS, Kerr T.

Am J Public Health. 2006 May;96(5):770-3. Epub 2006 Mar 29.

15.

Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.

Reddon H, Wood E, Tyndall M, Lai C, Hogg R, Montaner J, Kerr T.

AIDS Educ Prev. 2011 Oct;23(5):412-22. doi: 10.1521/aeap.2011.23.5.412.

16.

Should North America's first and only supervised injection facility (InSite) be expanded in British Columbia, Canada?

Jozaghi E, Andresen MM.

Harm Reduct J. 2013 Feb 16;10:1. doi: 10.1186/1477-7517-10-1.

17.

Estimated drug overdose deaths averted by North America's first medically-supervised safer injection facility.

Milloy MJ, Kerr T, Tyndall M, Montaner J, Wood E.

PLoS One. 2008 Oct 7;3(10):e3351. doi: 10.1371/journal.pone.0003351.

18.

Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture.

Small W, Shoveller J, Moore D, Tyndall M, Wood E, Kerr T.

Qual Health Res. 2011 Jun;21(6):743-56. doi: 10.1177/1049732311400919. Epub 2011 Mar 4.

PMID:
21378259
19.

Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users.

Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, Tyndall MW.

CMAJ. 2004 Sep 28;171(7):731-4.

20.

Employment among users of a medically supervised safer injection facility.

Richardson L, Wood E, Zhang R, Montaner J, Tyndall M, Kerr T.

Am J Drug Alcohol Abuse. 2008;34(5):519-25. doi: 10.1080/00952990802146308.

PMID:
18821450

Supplemental Content

Support Center